title: Effect of analogs with modified prenyl side chains on growth of serum deficient HL60 cells.
abstract: This study was organized by Professor Karl Folkers with the objective of finding derivatives of coenzyme Q which could be more effectively absorbed and would give better biomedical effects. In this series all the compounds are 2,3 dimethoxy, 5 methyl p benzoquinone with modified side chains in the 6 position. The modifications are primarily changes in chain length, unsaturation, methyl groups and addition of terminal phenyl groups. The test system evaluates the growth of serum deficient HL60, 3T3 and HeLa cells in the presence of coenzyme Q10 or coenzyme Q analogs. Short chain coenzyme Q homologues such as coenzyme Q2 give poor growth but compounds with saturated short aliphatic side chains from C10 to C18 produce good growth. Introduction of a single double bond at the 2' or 8' position in the aliphatic chain retains growth stimulation at low concentration but introduces inhibition at higher concentration. Introduction of a 3' methyl group in addition to the 2' enyl site in the side chain decreases the growth response and maintains inhibition. Addition of a terminal phenyl group to the side chain from C5 to C10 can produce analogs which give strong stimulation or strong inhibition of growth. The action of the analogs is in addition to the natural coenzyme Q in the cell and is not based on restoration of activity after depletion of normal coenzyme Q. The effects may be based on any of the sites in the cell where coenzyme Q functions. For example, coenzyme Q2 is known to decrease mitochondrial membrane potential whereas the analog with a 10C aliphatic side chain increases potential. Both of these compounds stimulate plasma membrane electron transport. Inhibition of apoptosis by coenzyme Q may also increase net cell proliferation and the 10C analog inhibits the permeability transition pore.
authors.affiliation: Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
authors.forename: I L
authors.initials: IL
authors.lastname: Sun
authors.forename: L E
authors.initials: LE
authors.lastname: Sun
authors.forename: E E
authors.initials: EE
authors.lastname: Sun
authors.forename: F L
authors.initials: FL
authors.lastname: Crane
authors.forename: R
authors.initials: R
authors.lastname: Willis
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001769:Blood; D002455:Cell Division / Q000187:drug effects*; D016895:Culture Media, Serum-Free; D018922:HL-60 Cells; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D017368:Protein Prenylation; D013329:Structure-Activity Relationship; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D016895:Culture Media, Serum-Free; D014451:Ubiquinone